Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taisuke Ishii

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Nihon Jinzo Gakkai Shi|January 9, 2019
[Drug-induced kidney injury of anticancer chemotherapeutic drugs]Yasuhiro Komatsu, Taisuke Ishii
Cancer Medicine|September 21, 2022
Differences in the performance of adjuvant chemotherapy between hemodialysis and nonhemodialysis patientsTaisuke Ishii, Tomone Watanabe, Takahiro Higashi
Cancer Medicine|June 11, 2022
Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclinesTaisuke Ishii, Tomone Watanabe, Takahiro Higashi
Kidney International|February 15, 2022
Is HIF activation Janus faced? The therapeutic effects of the HIF-2α inhibitorTaisuke Ishii, Tetsuhiro Tanaka, Masaomi Nangaku
Therapeutics and Clinical Risk Management|February 25, 2021
Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney DiseaseTaisuke Ishii, Tetsuhiro Tanaka, Masaomi Nangaku
Clinical Breast Cancer|February 9, 2022
Cardiac Function Checkup During Trastuzumab Therapy Among Patients With Breast CancerTaisuke Ishii, Eriko Nakano, Tomone Watanabe, et al.
Cancer Medicine|July 3, 2020
Epidemiology and practice patterns for male breast cancer compared with female breast cancer in JapanTaisuke Ishii, Eriko Nakano, Tomone Watanabe, et al.
Cancer Medicine|September 9, 2025
Adjuvant Chemotherapy for Patients With Chronic Kidney Disease: A Study on Treatment Adoption and Associated FactorsTaisuke Ishii, Tomone Watanabe, Yuichi Ichinose, et al.
BMC Cancer|June 19, 2026
Prognostic outcomes of adjuvant chemotherapy in postoperative patients with cancer undergoing hemodialysis versus non-hemodialysis patients: a retrospective nationwide cohort studyTaisuke Ishii, Tomone Watanabe, Yuichi Ichinose, et al.
Kidney International|February 9, 2020
Prolyl hydroxylase inhibition protects the kidneys from ischemia via upregulation of glycogen storageMarie Ito, Tetsuhiro Tanaka, Taisuke Ishii, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Nihon Jinzo Gakkai Shi|January 9, 2019
[Drug-induced kidney injury of anticancer chemotherapeutic drugs]Yasuhiro Komatsu, Taisuke Ishii
Cancer Medicine|September 21, 2022
Differences in the performance of adjuvant chemotherapy between hemodialysis and nonhemodialysis patientsTaisuke Ishii, Tomone Watanabe, Takahiro Higashi
Cancer Medicine|June 11, 2022
Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclinesTaisuke Ishii, Tomone Watanabe, Takahiro Higashi
Kidney International|February 15, 2022
Is HIF activation Janus faced? The therapeutic effects of the HIF-2α inhibitorTaisuke Ishii, Tetsuhiro Tanaka, Masaomi Nangaku
Therapeutics and Clinical Risk Management|February 25, 2021
Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney DiseaseTaisuke Ishii, Tetsuhiro Tanaka, Masaomi Nangaku
Clinical Breast Cancer|February 9, 2022
Cardiac Function Checkup During Trastuzumab Therapy Among Patients With Breast CancerTaisuke Ishii, Eriko Nakano, Tomone Watanabe, et al.
Cancer Medicine|July 3, 2020
Epidemiology and practice patterns for male breast cancer compared with female breast cancer in JapanTaisuke Ishii, Eriko Nakano, Tomone Watanabe, et al.
Cancer Medicine|September 9, 2025
Adjuvant Chemotherapy for Patients With Chronic Kidney Disease: A Study on Treatment Adoption and Associated FactorsTaisuke Ishii, Tomone Watanabe, Yuichi Ichinose, et al.
BMC Cancer|June 19, 2026
Prognostic outcomes of adjuvant chemotherapy in postoperative patients with cancer undergoing hemodialysis versus non-hemodialysis patients: a retrospective nationwide cohort studyTaisuke Ishii, Tomone Watanabe, Yuichi Ichinose, et al.
Kidney International|February 9, 2020
Prolyl hydroxylase inhibition protects the kidneys from ischemia via upregulation of glycogen storageMarie Ito, Tetsuhiro Tanaka, Taisuke Ishii, et al.
Pageof 3